

The recombinant human TNFRSF10B (DR5/TRAIL-R2) by Applied Biological Materials is expressed in E. coli with >95% purity by SDS-PAGE and an ED50 of <0.2 ng/mL. This 15 kDa tag-free lyophilized death receptor protein supports TRAIL-mediated apoptosis research, cancer biology, and TRAIL pathway pharmacology studies. Available in 50 µg (Z102245), 200 µg (Z102247), and 1.0 mg (Z102249).


